The precise administration of compounds designed to selectively induce apoptosis, or programmed cell death, in cells that have entered a state of irreversible replicative senescence. Successful application clears these dysfunctional cells from tissues, thereby reducing the chronic secretion of pro-inflammatory SASP factors. This is a targeted strategy for cellular rejuvenation.
Origin
This concept is relatively new, stemming from geroscience and pharmacology, where specific molecules are identified to target the survival pathways unique to senescent cells. Application implies a controlled therapeutic strategy aimed at clearing accumulated cellular debris that impairs normal physiology. The origin lies in differential pathway targeting.
Mechanism
Senolytic agents operate by inhibiting anti-apoptotic pathways that senescent cells rely upon for survival, such as the BCL-2 family proteins. Once this survival mechanism is blocked, the cell initiates its intrinsic apoptotic cascade, leading to its clearance by phagocytes. This process alleviates the burden of the inflammatory microenvironment, which in turn can restore optimal sensitivity to endogenous hormones.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.